Second attempt of Cabergoline withdrawal in patients with prolactinomas after a failed first attempt : is it worthwhile?

Second attempt of Cabergoline withdrawal in patients with prolactinomas after a failed first attempt : is it worthwhile?

Successful discontinuation of cabergoline (CAB) treatment has been reported in 31 to 74% of prolactinomas patients treated for at least two years. In contrast, it is not well established whether CAB therapy can be successfully withdrawn after a failed first attempt. This prospective open trial was...

Full description

Bibliographic Details
Main Authors: Lucio eVilar, José Luciano eAlbuquerque, Patricia Sampaio Gadelha, Frederico eRangel Filho, Aline Maria C. Siqueira, Maíra Melo Fonseca, Karoline Frazão Viana, Barbara Sales Gomes, Ruy eLyra
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-02-01
Series:Frontiers in Endocrinology
Subjects:
Dopamine Agonists
Prolactinoma
Recurrence
cabergoline
second withdrawal
Online Access:http://journal.frontiersin.org/Journal/10.3389/fendo.2015.00011/full

Similar Items

Similar Items